The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: September 2025

EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region
Gastrointestinal

EUDRACAP® Colon: Enabling Targeted Drug Delivery to the Ileo-Colonic Region

SEP 29, 2025
Multi-omic data from study of the longest-lived person ever recorded sheds light on biology of ageing
Pharma & Human Health

Multi-omic data from study of the longest-lived person ever recorded sheds light on biology of ageing

SEP 26, 2025
Study finds significant health benefits in adolescents with obesity treated with FMT
Pharma & Human Health

Study finds significant health benefits in adolescents with obesity treated with FMT

SEP 24, 2025
Connection among gut fungi, genetics and disease risk in humans identified
Pharma & Human Health

Connection among gut fungi, genetics and disease risk in humans identified

SEP 19, 2025
resbiotic® Raises $14.5M to Accelerate Growth of Science-Backed Gut-X Axis Health Platform
Pharma & Human Health

resbiotic® Raises $14.5M to Accelerate Growth of Science-Backed Gut-X Axis Health Platform

SEP 16, 2025
New strains of beneficial gut bacteria discovered in animals
Animal Health

New strains of beneficial gut bacteria discovered in animals

SEP 15, 2025
CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence
GMO & Synbio

CRISPR study reveals surprising role of Cas9 as a guardian of bacterial defence

SEP 11, 2025
Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies
Biotics and Supplements

Persephone Biosciences Unveils First-Of-Its-Kind Synbiotic Designed To Restore Critical Gut Microbes In Babies

SEP 10, 2025
EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment
Finance

EXPERT’Biome, CDMO By Lallemand, Acquires Bacthera Equipment

SEP 9, 2025
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
Pharma & Human Health

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

SEP 8, 2025
MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
Editor's Choice

MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline

SEP 4, 2025